title: Melanoma: more answers, more questions.
authors.affiliation: Earle A. Chiles Research Institute, Providence Cancer Center, Portland, Oregon 97213, USA. walter.urba@providence.org
authors.forename: Walter J
authors.initials: WJ
authors.lastname: Urba
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D004357:Drug Synergism; D064420:Drug-Related Side Effects and Adverse Reactions / Q000473:pathology*; D005260:Female; D006801:Humans; D000074324:Ipilimumab; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics* / Q000276:immunology*; D009362:Neoplasm Metastasis / Q000188:drug therapy* / Q000276:immunology*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D000074324:Ipilimumab; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf